Accumulating evidence confirms that SIRT3 attenuation or ablation accelerates the development of aging-related diseases, including cancers, metabolic syndromes, cardiovascular diseases, and neurodegenerative diseases[12,20–21]. This evidence concerns the gene SIRT3 and cardiovascular disorder.